PUBLISHER: Grand View Research | PRODUCT CODE: 2151481
PUBLISHER: Grand View Research | PRODUCT CODE: 2151481
Europe Peripheral Liquid Embolic Agents Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Country, And Segment Forecasts, 2026 - 2036
Europe Peripheral Liquid Embolic Agents Market Summary
The Europe peripheral liquid embolic agents market size was valued at USD 104.3 million in 2025 and is projected to grow from USD 109.4 million in 2026 to USD 178.6 million by 2036, at a CAGR of 5.0% from 2026 to 2036. The rising burden of peripheral artery disease and other vascular disorders is supporting demand for endovascular interventions. In addition, the growing preference for minimally invasive vascular procedures is contributing to the adoption of catheter-based treatment approaches due to lower procedural trauma, shorter hospital stays, and faster patient recovery.
The expansion of interventional radiology and vascular surgery services, together with improvements in catheter-based technologies and embolization techniques, is further supporting the use of liquid embolic agents in peripheral vascular procedures. An aging population and increasing healthcare focus on managing chronic vascular conditions are also expected to support demand for advanced peripheral embolization solutions across Europe.
For instance, the European Society of Cardiology's (ESC) Cardiovascular Disease Statistics 2025 reports that 9.3 million new cardiovascular disease cases were recorded across ESC member countries in 2023, with peripheral arterial disease (PAD) accounting for 24% of new CVD cases. The report further estimates 121 million people living with CVD, while PAD prevalence represented 19% of people living with CVD, and PAD incidence reached 123.6 per 100,000 person-years. Among individuals aged 70 years and older, PAD incidence was substantially higher at 1,090 per 100,000 person-years, highlighting the significant vascular disease burden associated with population aging. These findings support demand for peripheral vascular interventions and advanced embolization technologies, including liquid embolic agents, as healthcare systems address the growing need for diagnosis and treatment of peripheral vascular disease.
In addition, the availability of specialized vascular centers, established endovascular treatment pathways, and growing expertise among vascular specialists are supporting the adoption of embolization procedures to treat aneurysm-related complications. Improvements in vascular imaging and surveillance following EVAR are enabling earlier identification and management of Type II endoleaks, increasing the utilization of peripheral liquid embolic agents. According to data published by the National Vascular Registry in 2025, when aneurysms develop in the aorta, they most frequently occur below the arteries supplying the kidneys and are known as infra-renal AAAs. The NVR received information on 2,511 people who had an elective repair of an unruptured infra-renal AAA in 2024, which corresponds to an estimated case-ascertainment rate for the UK of 91% (for England = 91%; for Wales = >100%; for Scotland = 64%; for NI = 100%)
The rising incidence and clinical diagnosis of varicocele in the UK are contributing to growth in the market by increasing demand for minimally invasive embolization procedures. Varicocele is one of the most common venous disorders affecting the male reproductive system. It is frequently associated with chronic scrotal pain, testicular dysfunction, and male infertility, prompting a growing number of patients to seek treatment. Transcatheter embolization has become an established therapeutic option for varicocele management, offering a minimally invasive alternative to surgical ligation. During the procedure, liquid embolic agents are used to achieve targeted occlusion of incompetent testicular veins, eliminate abnormal venous reflux, and preserve surrounding vascular structures.
Europe Peripheral Liquid Embolic Agents Market Report Segmentation
This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2036. For this study, Grand View Research has segmented the Europe peripheral liquid embolic agents market report based on product, application, end use, and country:
- Product Outlook (Revenue, USD Million, 2021 - 2036)
- Ethylene Vinyl Alcohol Copolymer (EVOH)
- Cyanoacrylates / tissue glues combined
- n-butyl cyanoacrylate (n-BCA)
- n-hexyl cyanoacrylate (n-HCA)
- Others liquid embolics
- Application Outlook (Revenue, USD Million, 2021 - 2036)
- Peripheral Vascular Hemorrhage
- Hypervascular Tumors
- Peripheral Vascular Malformations / AVMs
- Aneurysms / Pseudoaneurysms
- Type II Endoleaks
- Portal Vein Embolization (PVE)
- Venous Applications (varicocele, PCS, varicose veins)
- Other Peripheral Embolization Applications
- End Use Outlook (Revenue, USD Million, 2021 - 2036)
- Hospitals
- Others
- Country Outlook (Revenue, USD Million, 2021-2036)
- UK
- Germany
- France
- Italy
- Spain
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. End Use
- 1.1.4. Estimates and forecast timeline
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.5. Details of primary research
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.1.1. Approach 1: Commodity flow approach
- 1.7.2. Volume price analysis (Model 2)
- 1.7.2.1. Approach 2: Volume price analysis
- 1.7.1. Commodity flow analysis (Model 1)
- 1.8. Research Scope and Assumptions
- 1.8.1. List of Secondary Sources
- 1.8.2. List of Primary Sources
- 1.8.3. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Europe Peripheral Liquid Embolic Agents Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Drivers Analysis
- 3.2.1.1. Increasing burden of peripheral vascular disease
- 3.2.1.2. Growing adoption of minimally invasive endovascular procedures
- 3.2.1.3. Expansion of liquid embolization across peripheral vascular indications
- 3.2.1.4. Advances in embolic-material visualization and delivery control
- 3.2.1.5. Increasing clinical evidence for newer liquid embolic systems
- 3.2.2. Market Restraints Analysis
- 3.2.2.1. Stringent EU medical-device regulatory requirements
- 3.2.2.2. Limited indication-specific clinical evidence for newer liquid embolic agents
- 3.2.3. Market Opportunity Analysis
- 3.2.3.1. Expansion of liquid embolics in peripheral hemorrhage management
- 3.2.3.2. Increasing use in complex venous and vascular interventions
- 3.2.3.3. Development of more controllable and image-visible embolic formulations
- 3.2.3.4. Expansion of interventional oncology applications
- 3.2.4. Market Challenge Analysis
- 3.2.4.1. Competition from coils, plugs, particles, and other established embolization modalities
- 3.2.4.2. High dependence on operator expertise and complex vascular anatomy
- 3.2.1. Market Drivers Analysis
- 3.3. Europe peripheral liquid Embolic Agents Market Analysis Tools
- 3.3.1. Porter's Analysis
- 3.3.1.1. Bargaining power of the suppliers
- 3.3.1.2. Bargaining power of the buyers
- 3.3.1.3. Threats of substitution
- 3.3.1.4. Threats from new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental landscape
- 3.3.2.5. Legal landscape
- 3.3.1. Porter's Analysis
Chapter 4. Europe Peripheral Liquid Embolic Agents Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Europe Peripheral Liquid Embolic Agents Market: Product Movement Analysis, 2025 & 2036 (USD Million)
- 4.3. Europe Peripheral Liquid Embolic Agents Market Size & Trend Analysis, by Product, 2021 to 2036 (USD Million)
- 4.4. Ethylene Vinyl Alcohol Copolymer (EVOH)
- 4.4.1. Ethylene Vinyl Alcohol Copolymer (EVOH) market revenue estimates and forecasts, 2021 - 2036 (USD Million)
- 4.5. Cyanoacrylates / tissue glues combined
- 4.5.1. Cyanoacrylates / tissue glues combined market revenue estimates and forecasts, 2021 - 2036 (USD Million)
- 4.5.2. n-butyl cyanoacrylate (n-BCA)
- 4.5.2.1. n-butyl cyanoacrylate (n-BCA) market revenue estimates and forecasts, 2021 - 2036 (USD Million)
- 4.5.3. n-hexyl cyanoacrylate (n-HCA)
- 4.5.3.1. n-hexyl cyanoacrylate (n-HCA) market revenue estimates and forecasts, 2021 - 2036 (USD Million)
- 4.6. Other Liquid Embolics
- 4.6.1. Other Embolic Agents market revenue estimates and forecasts, 2021 - 2036 (USD Million)
Chapter 5. Europe Peripheral Liquid Embolic Agents Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Europe Peripheral Liquid Embolic Agents Market: Application Movement Analysis, 2025 & 2036 (USD Million)
- 5.3. Europe Peripheral Liquid Embolic Agents Market Size & Trend Analysis, by Application 2021 to 2036 (USD Million)
- 5.4. Peripheral Vascular Hemorrhage
- 5.4.1. Peripheral Vascular Hemorrhage market revenue estimates and forecasts, 2021 - 2036 (USD Million)
- 5.5. Hypervascular Tumors
- 5.5.1. Hypervascular Tumors market revenue estimates and forecasts, 2021 - 2036 (USD Million)
- 5.6. Peripheral Vascular Malformations / AVMs
- 5.6.1. Peripheral Vascular Malformations/AVMs market revenue estimates and forecasts, 2021 - 2036 (USD Million)
- 5.7. Aneurysms / Pseudoaneurysms
- 5.7.1. Aneurysms / Pseudoaneurysms market revenue estimates and forecasts, 2021 - 2036 (USD Million)
- 5.8. Type II Endoleaks
- 5.8.1. Type II Endoleaks market revenue estimates and forecasts, 2021 - 2036 (USD Million)
- 5.9. Portal Vein Embolization (PVE)
- 5.9.1. Portal Vein Embolization (PVE)market revenue estimates and forecasts, 2021 - 2036 (USD Million)
- 5.10. Venous Applications (varicocele, PCS, varicose veins)
- 5.10.1. Venous Applications (varicocele, PCS, varicose veins) market revenue estimates and forecasts, 2021 - 2036 (USD Million)
- 5.11. Other Peripheral Embolization Applications
- 5.11.1. Other Peripheral Embolization Applications market revenue estimates and forecasts, 2021 - 2036 (USD Million)
Chapter 6. Europe Peripheral Liquid Embolic Agents Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Europe Peripheral Liquid Embolic Agents Market: End Use Movement Analysis, 2025 & 2036 (USD Million)
- 6.3. Europe Peripheral Liquid Embolic Agents Market Size & Trend Analysis, by End Use, 2021 to 2036 (USD Million)
- 6.4. Hospitals
- 6.4.1. Hospitals market revenue estimates and forecasts, 2021 - 2036 (USD Million)
- 6.5. Others
- 6.5.1. Others market revenue estimates and forecasts, 2021 - 2036 (USD Million)
Chapter 7. Europe Peripheral Liquid Embolic Agents Market: Regional Estimates & Trend Analysis by Product, Application, and End Use
- 7.1. Country Dashboard
- 7.2. Market Size and Trend Analysis, 2021 to 2036
- 7.3. Europe
- 7.3.1. Europe peripheral liquid embolic agents market estimates and forecasts, 2021 - 2036 (USD Million)
- 7.3.2. UK
- 7.3.2.1. Key country dynamics
- 7.3.2.2. Competitive scenario
- 7.3.2.3. Regulatory framework
- 7.3.2.4. Reimbursement scenario
- 7.3.2.5. UK peripheral liquid embolic agents market estimates and forecasts, 2021 - 2036 (USD Million)
- 7.3.3. Germany
- 7.3.3.1. Key country dynamics
- 7.3.3.2. Competitive scenario
- 7.3.3.3. Regulatory framework
- 7.3.3.4. Reimbursement scenario
- 7.3.3.5. Germany peripheral liquid embolic agents market estimates and forecasts, 2021 - 2036 (USD Million)
- 7.3.4. France
- 7.3.4.1. Key country dynamics
- 7.3.4.2. Competitive scenario
- 7.3.4.3. Regulatory framework
- 7.3.4.4. Reimbursement scenario
- 7.3.4.5. France peripheral liquid embolic agents market estimates and forecasts, 2021 - 2036 (USD Million)
- 7.3.5. Italy
- 7.3.5.1. Key country dynamics
- 7.3.5.2. Competitive scenario
- 7.3.5.3. Regulatory framework
- 7.3.5.4. Reimbursement scenario
- 7.3.5.5. Italy peripheral liquid embolic agents market estimates and forecasts, 2021 - 2036 (USD Million)
- 7.3.6. Spain
- 7.3.6.1. Key country dynamics
- 7.3.6.2. Competitive scenario
- 7.3.6.3. Regulatory framework
- 7.3.6.4. Reimbursement scenario
- 7.3.6.5. Spain peripheral liquid embolic agents market estimates and forecasts, 2021 - 2036 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis by Key Market Participants
- 8.2. Company Categorization
- 8.3. Company Market Share Analysis, 2025
- 8.4. Company Heat Map Analysis
- 8.5. Strategy Mapping
- 8.5.1. Expansion
- 8.5.2. Mergers & Acquisition
- 8.5.3. Partnerships & Collaborations
- 8.5.4. New Technology Launches
- 8.5.5. Research And Development
- 8.5.6. Company Profiles
- 8.5.7. Medtronic
- 8.5.7.1. Company overview
- 8.5.7.2. Financial performance
- 8.5.7.3. Product Benchmarking
- 8.5.7.4. Strategic initiatives
- 8.5.8. BALT Group
- 8.5.8.1. Company overview
- 8.5.8.2. Financial performance
- 8.5.8.3. Product Benchmarking
- 8.5.8.4. Strategic initiatives
- 8.5.9. GEM S.r.l. (H.B. Fuller)
- 8.5.9.1. Company overview
- 8.5.9.2. Financial performance
- 8.5.9.3. Product Benchmarking
- 8.5.9.4. Strategic initiatives
- 8.5.10. Terumo Medical Corporation (MicroVention)
- 8.5.10.1. Company overview
- 8.5.10.2. Financial performance
- 8.5.10.3. Product Benchmarking
- 8.5.10.4. Strategic initiatives
- 8.5.11. B. Braun SE
- 8.5.11.1. Company overview
- 8.5.11.2. Financial performance
- 8.5.11.3. Product Benchmarking
- 8.5.11.4. Strategic initiatives
- 8.5.12. Qmedics
- 8.5.12.1. Company overview
- 8.5.12.2. Financial performance
- 8.5.12.3. Product Benchmarking
- 8.5.12.4. Strategic initiatives
- 8.5.13. NeuroSafe Medical / Sirtex Medical
- 8.5.13.1. Company overview
- 8.5.13.2. Financial performance
- 8.5.13.3. Product Benchmarking
- 8.5.13.4. Strategic initiatives
- 8.5.14. Johnson & Johnson MedTech (Cordis)
- 8.5.14.1. Company overview
- 8.5.14.2. Financial performance
- 8.5.14.3. Product Benchmarking
- 8.5.14.4. Strategic initiatives
- 8.5.15. Peters Surgical
- 8.5.15.1. Company overview
- 8.5.15.2. Financial performance
- 8.5.15.3. Product Benchmarking
- 8.5.15.4. Strategic initiatives
- 8.5.16. Boston Scientific Corporation
- 8.5.16.1. Company overview
- 8.5.16.2. Financial performance
- 8.5.16.3. Product Benchmarking
- 8.5.16.4. Strategic initiatives
- 8.5.17. BlackSwan Vascular / Sirtex Medical
- 8.5.17.1. Company overview
- 8.5.17.2. Financial performance
- 8.5.17.3. Product Benchmarking
- 8.5.17.4. Strategic initiatives
List of Tables
- Table 1 List of Abbreviation
- Table 2 Europe peripheral liquid embolic agents market, by product,2021 - 2036 (USD Million)
- Table 3 Europe peripheral liquid embolic agents market, by application,2021 - 2036 (USD Million)
- Table 4 Europe peripheral liquid embolic agents market, by end use,2021 - 2036 (USD Million)
- Table 5 UK peripheral liquid embolic agents market, by product,2021 - 2036 (USD Million)
- Table 6 UK peripheral liquid embolic agents market, by application,2021 - 2036 (USD Million)
- Table 7 UK peripheral liquid embolic agents market, by end use,2021 - 2036 (USD Million)
- Table 8 France peripheral liquid embolic agents market, by product,2021 - 2036 (USD Million)
- Table 9 France peripheral liquid embolic agents market, by application,2021 - 2036 (USD Million)
- Table 10 France peripheral liquid embolic agents market, by end use,2021 - 2036 (USD Million)
- Table 11 Germany peripheral liquid embolic agents market, by product,2021 - 2036 (USD Million)
- Table 12 Germany peripheral liquid embolic agents market, by application,2021 - 2036 (USD Million)
- Table 13 Germany peripheral liquid embolic agents market, by end use,2021 - 2036 (USD Million)
- Table 14 Italy peripheral liquid embolic agents market, by product,2021 - 2036 (USD Million)
- Table 15 Italy peripheral liquid embolic agents market, by application,2021 - 2036 (USD Million)
- Table 16 Italy peripheral liquid embolic agents market, by end use,2021 - 2036 (USD Million)
- Table 17 Spain peripheral liquid embolic agents market, by product,2021 - 2036 (USD Million)
- Table 18 Spain peripheral liquid embolic agents market, by application,2021 - 2036 (USD Million)
- Table 19 Spain peripheral liquid embolic agents market, by end use,2021 - 2036 (USD Million)
List of Figures
- Fig. 1 Europe peripheral liquid embolic agents market segmentation
- Fig. 2 Market research process
- Fig. 3 Information procurement
- Fig. 4 Data analysis models
- Fig. 5 Market formulation and validation
- Fig. 6 Data validating & publishing
- Fig. 7 Market snapshot
- Fig. 8 Segment snapshot
- Fig. 9 Competitive landscape snapshot
- Fig. 10 Europe peripheral liquid embolic agents market size and growth prospects (USD Million)
- Fig. 11 Europe peripheral liquid embolic agents market: Industry Value Chain Analysis
- Fig. 12 Europe peripheral liquid embolic agents market: Market Dynamics
- Fig. 13 Europe peripheral liquid embolic agents market: PORTER's Analysis
- Fig. 14 Europe peripheral liquid embolic agents market: PESTEL Analysis
- Fig. 15 Europe peripheral liquid embolic agents market share by product, 2025 & 2036 (USD Million)
- Fig. 16 Europe peripheral liquid embolic agents market, by product: market share, 2025 & 2036
- Fig. 17 Ethylene Vinyl Alcohol Copolymer (EVOH) market estimates & forecasts, 2021 - 2036 (Revenue, USD Million)
- Fig. 18 Cyanoacrylates / tissue glues combined market estimates & forecasts, 2021 - 2036 (Revenue, USD Million)
- Fig. 19 n-butyl cyanoacrylate (n-BCA) market estimates & forecasts, 2021 - 2036 (Revenue, USD Million)
- Fig. 20 n-hexyl cyanoacrylate (n-HCA) market estimates & forecasts, 2021 - 2036 (Revenue, USD Million)
- Fig. 21 Other liquid embolics market estimates & forecasts, 2021 - 2036 (Revenue, USD Million)
- Fig. 22 Europe peripheral liquid embolic agents market share by application, 2025 & 2036 (USD Million)
- Fig. 23 Europe peripheral liquid embolic agents market, by application: market share, 2025 & 2036
- Fig. 24 Peripheral vascular hemorrhage market estimates & forecasts, 2021 - 2036 (Revenue, USD Million)
- Fig. 25 Hypervascular tumors market estimates & forecasts, 2021 - 2036 (Revenue, USD Million)
- Fig. 26 Peripheral vascular malformations / AVMs market estimates & forecasts, 2021 - 2036 (Revenue, USD Million)
- Fig. 27 Aneurysms / pseudoaneurysms market estimates & forecasts, 2021 - 2036 (Revenue, USD Million)
- Fig. 28 Type II endoleaks market estimates & forecasts, 2021 - 2036 (Revenue, USD Million)
- Fig. 29 Portal Vein Embolization (PVE) market estimates & forecasts, 2021 - 2036 (Revenue, USD Million)
- Fig. 30 Venous applications (varicocele, PCS, varicose veins) market estimates & forecasts, 2021 - 2036 (Revenue, USD Million)
- Fig. 31 Other peripheral embolization applications market estimates & forecasts, 2021 - 2036 (Revenue, USD Million)
- Fig. 32 Europe peripheral liquid embolic agents market share by end use, 2025 & 2036 (USD Million)
- Fig. 33 Europe peripheral liquid embolic agents market, by end use: market share, 2025 & 2036
- Fig. 34 Hospitals market estimates & forecasts, 2021 - 2036 (Revenue, USD Million)
- Fig. 35 Others market estimates & forecasts, 2021 - 2036 (Revenue, USD Million)
- Fig. 36 Country marketplace: key takeaways
- Fig. 37 UK peripheral liquid embolic agents market estimates and forecasts, 2021 - 2036 (USD Million)
- Fig. 38 Germany peripheral liquid embolic agents market estimates and forecasts, 2021 - 2036 (USD Million)
- Fig. 39 France peripheral liquid embolic agents market estimates and forecasts, 2021 - 2036 (USD Million)
- Fig. 40 Italy peripheral liquid embolic agents market estimates and forecasts, 2021 - 2036 (USD Million)
- Fig. 41 Spain peripheral liquid embolic agents market estimates and forecasts, 2021 - 2036 (USD Million)
- Fig. 42 Key company categorization
- Fig. 43 Company market positioning
- Fig. 44 Key company market share analysis, 2025
- Fig. 45 Strategic framework
